Results 231 to 240 of about 54,207 (313)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? [PDF]

, 2011
Jan K. Hennigs, Gunhild Keller, Hans Jörg Baumann, Friedemann Honecker, Stefan Kluge, Carsten Bokemeyer, Tim H. Brümmendorf, Hans Klose   +7 more
openalex   +1 more source

Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy. [PDF]

Pharmaceuticals (Basel)
Battaglia-Vieni A, Marchant V, Tejedor-Santamaria L, García-Caballero C, Flores-Salguero E, Ruiz-Torres MP, Rayego-Mateos S, Sanz AB, Ortiz A, Ruiz-Ortega M.   +9 more
europepmc   +1 more source

Periorbital edema and phototoxic rash associated with dasatinib: A case report. [PDF]

SAGE Open Med Case Rep
Ugurlu BO, Malkan UY.
europepmc   +1 more source

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib

, 2009
Charles Chuah
openalex   +2 more sources

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation [PDF]

, 2011
Burak Uz, O. Bektas, Eylem Eliaçık, Hakan Göker, Yücel Erbilgin, Müge Sayitoğlu, Nilgün Sayınalp, Salih Aksu, Yahya Büyükaşık, O. Özcebe, İbrahim C. Haznedaroğlu   +10 more
openalex   +1 more source

Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells. [PDF]

Leuk Res Rep
Kazama H, Wang YH, Tanaka J.
europepmc   +1 more source

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) [PDF]

, 2011
Hagop M. Kantarjian, Neil P. Shah, Jorge E. Cortés, Michele Baccarani, M B Agarwal, María Soledad Undurraga, Jianxiang Wang, Juan Julio Kassack Ipiña, Dong‐Wook Kim, Michinori Ogura, Carolina Pavlovsky, Christian Junghanß, Jorge Milone, Franck E. Nicolini, Tadeusz Robak, Jan Van Droogenbroeck, Edo Vellenga, M. Brigid Bradley‐Garelik, Chao Zhu, Andreas Hochhaus   +19 more
openalex   +1 more source

Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis. [PDF]

Support Care Cancer
Smit Y, Scheuter P, Lange MPM, Janssen JJWM, Posthuma EFM, Bekker CL, Hermens RPMG, Blijlevens NMA.   +7 more
europepmc   +1 more source

Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel^®), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia

, 2009
Yutaka Fujii, Manabu Amano, Taku Seriu
openalex   +2 more sources

Semi-synthesis and biological activities of heterocyclic compounds containing camphor. [PDF]

RSC Adv
Hamza ZS, Hozzein WN, El-Adl K, Okla MK, AbdElgayed G, Fadaly WAA, Mohamed HS.   +6 more
europepmc   +1 more source